Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 302,338 |
Ending reported balance
After 2026-03-18 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-18 · Grant · Acquired 1,800 · Balance 298,338 Row 2 · 2026-03-18 · Grant · Acquired 4,000 · Balance 302,338 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 20, 2023 Filed Dec 28, 2023 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 628 | $1.76 | $1,105.28 |
DisclosureSEC source: 0001214659-23-017030 · marketforms-63935.xml · nonDerivative · entry 14 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 235,516 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 19, 2023 Filed Dec 28, 2023 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 407 | $1.73 | $704.11 |
DisclosureSEC source: 0001214659-23-017030 · marketforms-63935.xml · nonDerivative · entry 13 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 234,888 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 18, 2023 Filed Dec 28, 2023 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 407 | $1.80 | $732.60 |
DisclosureSEC source: 0001214659-23-017030 · marketforms-63935.xml · nonDerivative · entry 12 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 234,481 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 15, 2023 Filed Dec 28, 2023 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 434 | $1.89 | $820.26 |
DisclosureSEC source: 0001214659-23-017030 · marketforms-63935.xml · nonDerivative · entry 11 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 234,074 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 14, 2023 Filed Dec 28, 2023 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 434 | $1.86 | $807.24 |
DisclosureSEC source: 0001214659-23-017030 · marketforms-63935.xml · nonDerivative · entry 10 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 233,640 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 13, 2023 Filed Dec 28, 2023 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 434 | $1.80 | $781.20 |
DisclosureSEC source: 0001214659-23-017030 · marketforms-63935.xml · nonDerivative · entry 9 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 233,206 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 12, 2023 Filed Dec 28, 2023 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 456 | $1.77 | $807.12 |
DisclosureSEC source: 0001214659-23-017030 · marketforms-63935.xml · nonDerivative · entry 8 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 232,772 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 11, 2023 Filed Dec 28, 2023 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 434 | $1.85 | $802.90 |
DisclosureSEC source: 0001214659-23-017030 · marketforms-63935.xml · nonDerivative · entry 7 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 232,316 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 08, 2023 Filed Dec 28, 2023 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 379 | $1.83 | $693.57 |
DisclosureSEC source: 0001214659-23-017030 · marketforms-63935.xml · nonDerivative · entry 6 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 231,882 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 07, 2023 Filed Dec 28, 2023 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 174 | $1.65 | $287.10 |
DisclosureSEC source: 0001214659-23-017030 · marketforms-63935.xml · nonDerivative · entry 5 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 231,503 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 06, 2023 Filed Dec 28, 2023 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 379 | $1.70 | $644.30 |
DisclosureSEC source: 0001214659-23-017030 · marketforms-63935.xml · nonDerivative · entry 4 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 231,329 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 05, 2023 Filed Dec 28, 2023 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 379 | $1.69 | $640.51 |
DisclosureSEC source: 0001214659-23-017030 · marketforms-63935.xml · nonDerivative · entry 3 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 230,950 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 04, 2023 Filed Dec 28, 2023 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 322 | $1.72 | $553.84 |
DisclosureSEC source: 0001214659-23-017030 · marketforms-63935.xml · nonDerivative · entry 2 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 230,571 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| December 01, 2023 Filed Dec 28, 2023 22:08 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 379 | $1.69 | $640.51 |
DisclosureSEC source: 0001214659-23-017030 · marketforms-63935.xml · nonDerivative · entry 1 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 230,249 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 30, 2023 Filed Dec 6, 2023 22:01 UTC Amendment | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 324 | $1.66 | $537.84 |
DisclosureSEC source: 0001214659-23-016097 · marketforms-63722.xml · nonDerivative · entry 9 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 229,870 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 29, 2023 Filed Dec 6, 2023 22:01 UTC Amendment | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 165 | $1.73 | $285.45 |
DisclosureSEC source: 0001214659-23-016097 · marketforms-63722.xml · nonDerivative · entry 8 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 229,546 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 28, 2023 Filed Dec 6, 2023 22:01 UTC Amendment | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 124 | $1.68 | $208.32 |
DisclosureSEC source: 0001214659-23-016097 · marketforms-63722.xml · nonDerivative · entry 7 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 229,381 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 27, 2023 Filed Dec 6, 2023 22:01 UTC Amendment | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 379 | $1.86 | $704.94 |
DisclosureSEC source: 0001214659-23-016097 · marketforms-63722.xml · nonDerivative · entry 6 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 229,257 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 22, 2023 Filed Dec 6, 2023 22:01 UTC Amendment | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $1.74 | $487.20 |
DisclosureSEC source: 0001214659-23-016097 · marketforms-63722.xml · nonDerivative · entry 5 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 228,878 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 21, 2023 Filed Dec 6, 2023 22:01 UTC Amendment | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 125 | $1.76 | $220.00 |
DisclosureSEC source: 0001214659-23-016097 · marketforms-63722.xml · nonDerivative · entry 4 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 228,598 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 20, 2023 Filed Dec 6, 2023 22:01 UTC Amendment | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 268 | $1.70 | $455.60 |
DisclosureSEC source: 0001214659-23-016097 · marketforms-63722.xml · nonDerivative · entry 3 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 228,473 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 17, 2023 Filed Dec 6, 2023 22:01 UTC Amendment | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $1.83 | $512.40 |
DisclosureSEC source: 0001214659-23-016097 · marketforms-63722.xml · nonDerivative · entry 2 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 228,205 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 16, 2023 Filed Dec 6, 2023 22:01 UTC Amendment | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 66 | $1.73 | $114.18 |
DisclosureSEC source: 0001214659-23-016097 · marketforms-63722.xml · nonDerivative · entry 1 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 227,925 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $1.78 | $498.40 |
DisclosureSEC source: 0001214659-23-015351 · marketforms-63541.xml · nonDerivative · entry 11 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 227,859 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 14, 2023 Filed Nov 17, 2023 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $1.73 | $484.40 |
DisclosureSEC source: 0001214659-23-015351 · marketforms-63541.xml · nonDerivative · entry 10 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 227,579 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 13, 2023 Filed Nov 17, 2023 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 236 | $1.75 | $413.00 |
DisclosureSEC source: 0001214659-23-015351 · marketforms-63541.xml · nonDerivative · entry 9 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 227,299 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 10, 2023 Filed Nov 17, 2023 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $1.77 | $495.60 |
DisclosureSEC source: 0001214659-23-015351 · marketforms-63541.xml · nonDerivative · entry 8 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 227,063 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 09, 2023 Filed Nov 17, 2023 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $1.82 | $509.60 |
DisclosureSEC source: 0001214659-23-015351 · marketforms-63541.xml · nonDerivative · entry 7 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 226,783 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 08, 2023 Filed Nov 17, 2023 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $2.00 | $560.00 |
DisclosureSEC source: 0001214659-23-015351 · marketforms-63541.xml · nonDerivative · entry 6 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 226,503 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 07, 2023 Filed Nov 17, 2023 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 96 | $2.01 | $192.96 |
DisclosureSEC source: 0001214659-23-015351 · marketforms-63541.xml · nonDerivative · entry 5 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 226,223 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 06, 2023 Filed Nov 17, 2023 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $2.03 | $568.40 |
DisclosureSEC source: 0001214659-23-015351 · marketforms-63541.xml · nonDerivative · entry 4 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 226,127 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 03, 2023 Filed Nov 17, 2023 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $2.06 | $576.80 |
DisclosureSEC source: 0001214659-23-015351 · marketforms-63541.xml · nonDerivative · entry 3 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 225,847 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 02, 2023 Filed Nov 17, 2023 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $1.97 | $551.60 |
DisclosureSEC source: 0001214659-23-015351 · marketforms-63541.xml · nonDerivative · entry 2 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 225,567 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| November 01, 2023 Filed Nov 17, 2023 22:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $1.85 | $518.00 |
DisclosureSEC source: 0001214659-23-015351 · marketforms-63541.xml · nonDerivative · entry 1 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 225,287 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 31, 2023 Filed Nov 3, 2023 21:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $2.01 | $562.80 |
DisclosureSEC source: 0001214659-23-014538 · marketforms-63457.xml · nonDerivative · entry 11 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 225,007 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 30, 2023 Filed Nov 3, 2023 21:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 255 | $2.04 | $520.20 |
DisclosureSEC source: 0001214659-23-014538 · marketforms-63457.xml · nonDerivative · entry 10 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 224,727 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 27, 2023 Filed Nov 3, 2023 21:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $1.98 | $554.40 |
DisclosureSEC source: 0001214659-23-014538 · marketforms-63457.xml · nonDerivative · entry 9 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 224,472 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 26, 2023 Filed Nov 3, 2023 21:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $1.99 | $557.20 |
DisclosureSEC source: 0001214659-23-014538 · marketforms-63457.xml · nonDerivative · entry 8 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 224,192 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 25, 2023 Filed Nov 3, 2023 21:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $1.99 | $557.20 |
DisclosureSEC source: 0001214659-23-014538 · marketforms-63457.xml · nonDerivative · entry 7 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 223,912 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 24, 2023 Filed Nov 3, 2023 21:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $2.10 | $588.00 |
DisclosureSEC source: 0001214659-23-014538 · marketforms-63457.xml · nonDerivative · entry 6 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 223,632 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 23, 2023 Filed Nov 3, 2023 21:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 255 | $2.08 | $530.40 |
DisclosureSEC source: 0001214659-23-014538 · marketforms-63457.xml · nonDerivative · entry 5 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 223,352 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 20, 2023 Filed Nov 3, 2023 21:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 64 | $2.08 | $133.12 |
DisclosureSEC source: 0001214659-23-014538 · marketforms-63457.xml · nonDerivative · entry 4 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 223,097 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 19, 2023 Filed Nov 3, 2023 21:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $2.05 | $574.00 |
DisclosureSEC source: 0001214659-23-014538 · marketforms-63457.xml · nonDerivative · entry 3 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 223,033 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 18, 2023 Filed Nov 3, 2023 21:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $1.96 | $548.80 |
DisclosureSEC source: 0001214659-23-014538 · marketforms-63457.xml · nonDerivative · entry 2 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 222,753 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 17, 2023 Filed Nov 3, 2023 21:02 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $2.24 | $627.20 |
DisclosureSEC source: 0001214659-23-014538 · marketforms-63457.xml · nonDerivative · entry 1 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 222,473 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 16, 2023 Filed Oct 17, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $2.03 | $568.40 |
DisclosureSEC source: 0001214659-23-013552 · marketforms-63405.xml · nonDerivative · entry 11 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,193 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 13, 2023 Filed Oct 17, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $2.07 | $579.60 |
DisclosureSEC source: 0001214659-23-013552 · marketforms-63405.xml · nonDerivative · entry 10 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,913 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 12, 2023 Filed Oct 17, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $2.13 | $596.40 |
DisclosureSEC source: 0001214659-23-013552 · marketforms-63405.xml · nonDerivative · entry 9 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,633 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 11, 2023 Filed Oct 17, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $2.04 | $571.20 |
DisclosureSEC source: 0001214659-23-013552 · marketforms-63405.xml · nonDerivative · entry 8 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,353 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
| October 10, 2023 Filed Oct 17, 2023 21:04 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 280 | $2.04 | $571.20 |
DisclosureSEC source: 0001214659-23-013552 · marketforms-63405.xml · nonDerivative · entry 7 Krogulski Kenneth · CIK 0001695580 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,073 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May16, 2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.